The results showed that intervention with the CD38 inhibitor decreased the number of senile plaques in the hippocampus and cortex of APP/PS1 mice compared to the model group, and the accumulation of Iba1 + microglia decreased. The gene discussed is APP; the disease is Senile plaques.